BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25339903)

  • 1. Gene and drug delivery system and potential treatment into inner ear for protection and regeneration.
    Kanzaki S
    Front Pharmacol; 2014; 5():222. PubMed ID: 25339903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism and Prevention of Spiral Ganglion Neuron Degeneration in the Cochlea.
    Zhang L; Chen S; Sun Y
    Front Cell Neurosci; 2021; 15():814891. PubMed ID: 35069120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injury and protection of spiral ganglion neurons.
    Duan B; Peng KA; Wang L
    Chin Med J (Engl); 2024 Mar; 137(6):651-656. PubMed ID: 37407223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Spiral Ganglion Neuron Regeneration as a Therapeutic Strategy in Sensorineural Hearing Loss.
    Wang M; Xu L; Han Y; Wang X; Chen F; Lu J; Wang H; Liu W
    Front Mol Neurosci; 2021; 14():829564. PubMed ID: 35126054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of Spiral Ganglion Neurons and Prevention of Auditory Neuropathy.
    Liu W; Wang X; Wang M; Wang H
    Adv Exp Med Biol; 2019; 1130():93-107. PubMed ID: 30915703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Small Molecule Neurotrophin-3 Analogue Promotes Inner Ear Neurite Outgrowth and Synaptogenesis
    Kempfle JS; Duro MV; Zhang A; Amador CD; Kuang R; Lu R; Kashemirov BA; Edge AS; McKenna CE; Jung DH
    Front Cell Neurosci; 2021; 15():666706. PubMed ID: 34335184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and Ultrastructural Changes to Type I Spiral Ganglion Neurons and Schwann Cells in the Deafened Guinea Pig Cochlea.
    Wise AK; Pujol R; Landry TG; Fallon JB; Shepherd RK
    J Assoc Res Otolaryngol; 2017 Dec; 18(6):751-769. PubMed ID: 28717876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-Linked TrkB Agonist: Cochlea-Targeted Delivery of a Neurotrophic Agent as a Strategy for the Treatment of Hearing Loss.
    Kempfle JS; Nguyen K; Hamadani C; Koen N; Edge AS; Kashemirov BA; Jung DH; McKenna CE
    Bioconjug Chem; 2018 Apr; 29(4):1240-1250. PubMed ID: 29485861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy Regulates the Survival of Hair Cells and Spiral Ganglion Neurons in Cases of Noise, Ototoxic Drug, and Age-Induced Sensorineural Hearing Loss.
    Guo L; Cao W; Niu Y; He S; Chai R; Yang J
    Front Cell Neurosci; 2021; 15():760422. PubMed ID: 34720884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Application of Mesenchymal Stem Cells for Cochlear Regeneration.
    Maharajan N; Cho GW; Jang CH
    In Vivo; 2021; 35(1):13-22. PubMed ID: 33402445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of neural degeneration in the human cochlea and auditory nerve: implications for cochlear implantation.
    Nadol JB
    Otolaryngol Head Neck Surg; 1997 Sep; 117(3 Pt 1):220-8. PubMed ID: 9334769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel drug delivery systems for inner ear protection and regeneration after hearing loss.
    Richardson RT; Wise AK; Andrew JK; O'Leary SJ
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1059-76. PubMed ID: 18817513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective ablation of inner hair cells and subsequent in-situ hair cell regeneration in the neonatal mouse cochlea.
    Xia M; Wu M; Zhao L; Ma J; Li W; Li H
    Hear Res; 2021 Aug; 407():108275. PubMed ID: 34089989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of neurotrophins for treatment of hearing loss.
    Gao WQ
    Mol Neurobiol; 1998; 17(1-3):17-31. PubMed ID: 9887444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated cell device approach for combined electrical stimulation and neurotrophic treatment of the deaf cochlea.
    Konerding WS; Janssen H; Hubka P; Tornøe J; Mistrik P; Wahlberg L; Lenarz T; Kral A; Scheper V
    Hear Res; 2017 Jul; 350():110-121. PubMed ID: 28463804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a model of cochlear lesions in rats to study potential gene therapy for sensorineural hearing loss.
    Wang Y; Qiao L; Chen Y; Wen L; Yue B; Qiu J; Wu S
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2147-54. PubMed ID: 26574172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New molecular therapies for the treatment of hearing loss.
    Ma Y; Wise AK; Shepherd RK; Richardson RT
    Pharmacol Ther; 2019 Aug; 200():190-209. PubMed ID: 31075354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of REST in the cochlea contributes to age-related hearing loss via the p53 apoptosis pathway.
    Li H; Lu M; Zhang H; Wang S; Wang F; Ma X; Liu J; Li X; Yang H; Shen H; Lv P
    Cell Death Dis; 2022 Apr; 13(4):343. PubMed ID: 35418568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival, synaptogenesis, and regeneration of adult mouse spiral ganglion neurons in vitro.
    Wei D; Jin Z; Järlebark L; Scarfone E; Ulfendahl M
    Dev Neurobiol; 2007 Jan; 67(1):108-22. PubMed ID: 17443776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal expression of neurotrophic factors accessible to spiral ganglion neurons in the auditory system of adult hearing and deafened rats.
    Bailey EM; Green SH
    J Neurosci; 2014 Sep; 34(39):13110-26. PubMed ID: 25253857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.